phase readout
saveNCT04139057: EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Xinqiao Hospital of Chongqing. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that